University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Location status: Recruiting
NCT Number: NCT06250582
The goal of this clinical trial is to investigate the use of virtual reality therapy in dialysis patients. The main question it aims to answer is: Does virtual reality improve symptom burden in dialysis patients and improve their mental wellbeing? Over a period of one month, one virtual reality therapy session of 30 minutes will be performed during each regular hemodialysis session. Since we will conduct a monocentric, crossover randomized controlled trial, the participants act as their own control group.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Zurich, Canton of Zurich, 8091, Switzerland
Location status: Recruiting
Hemodialysis is a lifesaving therapy for patients with end stage kidney disease but comes with a high burden of physical and emotional symptoms that lower quality of life in dialysis patients. Dialysis mediated complications such as drops in blood pressure, nausea and muscle cramps results in refusal and a negative perception of this treatment. In dialysis patients, treatment-related burden results in deterioration in health related quality of life. During the past few years, Virtual reality (VR) has become more affordable and found its way into households as entertainment electronics but stepwise also into medicine. VR enables the user to view, interact and be immersed in a multisensory 3D virtual world. The aim of the current study is to reduce dialysis-related burden of symptoms by using virtual reality therapy during regular dialysis sessions and thereby improve quality of life among dialysis patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A virtual reality therapy will be applied for 30 minutes. Patients will be wearing the glasses while lying in bed/chair during their regular dialysis session. Vital signs will be monitored repeatedly. At defined times, patients are asked to answer various questionnaires about their physical and mental health.
Time frame: 10 weeks
questionnaire
Time frame: 10 weeks
Heart rate (beats per minute)
Time frame: 10 weeks
Blood pressure (mm Hg)
Time frame: 10 weeks
questionnaire
Time frame: 10 weeks
questionnaire
Time frame: 10 weeks
Cronbach's alpha
Contact information is provided by the study sponsor or research team.
David Blum, Prof.
CONTACT
STefan Pelz, Dr. med.
CONTACT
David Blum
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04748770
Comorbidities, Dialysis
Amiens, France
View Trial DetailsNCT07262320
AKI, Acute Kidney Injury
Cochabamba, Bolivia
View Trial DetailsNCT06521801
Brain Diseases, Cardio-Renal Syndrome
London, United Kingdom
View Trial DetailsNCT07013175
Acute Kidney Injury, Critical Illness
Stockholm, Sweden
View Trial Details